Georgia Cancer Center (@gacancercenter) 's Twitter Profile
Georgia Cancer Center

@gacancercenter

Georgia’s innovation center for cancer clinical care & research. We unite research & practice to prevent, treat, & ultimately cure cancer illness. RT≠endorse

ID: 750767911288135680

linkhttps://linktr.ee/georgiacancercenter calendar_today06-07-2016 19:06:33

2,2K Tweet

1,1K Followers

353 Following

Augusta University (@aug_university) 's Twitter Profile Photo

Driven by the loss of her father to #cancer, Dr. Yan Cui dedicated her life to understanding the disease and finding a cure. Her 30-year career focuses on unraveling the complexities of #tumor microenvironments and #cancergrowth. Read more: jagwire.augusta.edu/georgia-cancer…

Driven by the loss of her father to #cancer, Dr. Yan Cui dedicated her life to understanding the disease and finding a cure. 

Her 30-year career focuses on unraveling the complexities of #tumor microenvironments and #cancergrowth.

Read more: jagwire.augusta.edu/georgia-cancer…
Avirup Guha, MBBS, MPH, FICOS, FACC, FAHA (@avirupguha) 's Twitter Profile Photo

New pub alert 🚨 Laterality of Radiation Therapy in Breast Cancer is Not Associated with Increased Risk for Coronary Artery Disease in the Contemporary Era. Massive work involving a meta-analysis and institutional cohort 1/4 advancesradonc.org/article/S2452-…

New pub alert 🚨 Laterality of Radiation Therapy in Breast Cancer is Not Associated with Increased Risk for Coronary Artery Disease in the Contemporary Era. Massive work involving a meta-analysis and institutional cohort 1/4
advancesradonc.org/article/S2452-…
UroToday.com (@urotoday) 's Twitter Profile Photo

Advancing treatment for high-risk biochemical recurrence #ProstateCancer. Alex Chehrazi-Raffle, MD @cityofhop sits with Zach Klaassen Georgia Cancer Center to discuss the #ARASTEP trial of ADT + Darolutamide vs. ADT alone on UroToday > bit.ly/4d2DgsD

Advancing treatment for high-risk biochemical recurrence #ProstateCancer. <a href="/arafflemd/">Alex Chehrazi-Raffle, MD</a> @cityofhop sits with <a href="/zklaassen_md/">Zach Klaassen</a> <a href="/GACancerCenter/">Georgia Cancer Center</a> to discuss the #ARASTEP trial of ADT + Darolutamide vs. ADT alone on UroToday &gt; bit.ly/4d2DgsD
UroToday.com (@urotoday) 's Twitter Profile Photo

Bladder-sparing chemoradiation for localized #BladderCancer: addressing the unmet need. Brent Rose, MD UC San Diego joins Zach Klaassen Georgia Cancer Center to discuss advances in bladder-sparing therapies for localized bladder cancer > bit.ly/4coCw0D

Bladder-sparing chemoradiation for localized #BladderCancer: addressing the unmet need. Brent Rose, MD <a href="/UCSanDiego/">UC San Diego</a> joins <a href="/zklaassen_md/">Zach Klaassen</a> <a href="/GACancerCenter/">Georgia Cancer Center</a> to discuss advances in bladder-sparing therapies for localized bladder cancer &gt; bit.ly/4coCw0D
UroToday.com (@urotoday) 's Twitter Profile Photo

Cretostimogene grenadenorepvec: At the CORE and forming BONDs in high-risk #NMIBC and PIVOTing into intermediate-risk NMIBC. Zach Klaassen Georgia Cancer Center discusses recent advances in this disease space > bit.ly/46UJ5EE CG Oncology, Inc. Society of Urologic Oncology

Cretostimogene grenadenorepvec: At the CORE and forming BONDs in high-risk #NMIBC and PIVOTing into intermediate-risk NMIBC. <a href="/zklaassen_md/">Zach Klaassen</a> <a href="/GACancerCenter/">Georgia Cancer Center</a> discusses recent advances in this disease space &gt; bit.ly/46UJ5EE <a href="/cgoncology/">CG Oncology, Inc.</a> <a href="/UroOnc/">Society of Urologic Oncology</a>
Augusta University (@aug_university) 's Twitter Profile Photo

Representatives with Hyundai Hope On Wheels presented a $400,000 Scholar Hope Grant to Theodore Johnson, MD, PhD, at the ChildrensHospitalGA to support pediatric brain cancer research at Augusta University’s Georgia Cancer Center. Discover more: jagwire.augusta.edu/hyundai-invest…

Representatives with Hyundai Hope On Wheels presented a $400,000 Scholar Hope Grant to Theodore Johnson, MD, PhD, at the <a href="/GAChildrens/">ChildrensHospitalGA</a> to support pediatric brain cancer research at Augusta University’s <a href="/GACancerCenter/">Georgia Cancer Center</a>.

Discover more: jagwire.augusta.edu/hyundai-invest…
UroToday.com (@urotoday) 's Twitter Profile Photo

#TesticularCancer treatment and #Cardiovascular health: Understanding the long-term risks. Khalid Y. Alkhatib, MD, MMSc Penn Medicine sits down with Zach Klaassen Georgia Cancer Center to discuss the increased risk of CV issues for testicular cancer #survivors > bit.ly/3VvvCiK

#TesticularCancer treatment and #Cardiovascular health: Understanding the long-term risks. <a href="/Khalid_Alkhatib/">Khalid Y. Alkhatib, MD, MMSc</a> <a href="/PennMedicine/">Penn Medicine</a> sits down with <a href="/zklaassen_md/">Zach Klaassen</a> <a href="/GACancerCenter/">Georgia Cancer Center</a> to discuss the increased risk of CV issues for testicular cancer #survivors &gt; bit.ly/3VvvCiK
UroToday.com (@urotoday) 's Twitter Profile Photo

Navigating the Nuances: Exploring imaging options and impact to treatment strategies in #nmCPRC. Ryan Malone, MD First Urology joins Zach Klaassen Georgia Cancer Center in this conversation focusing on the evolving role of PSMA PET imaging. #WatchNow > bit.ly/42lRAaT Bayer U.S. 🇺🇸

Navigating the Nuances: Exploring imaging options and impact to treatment strategies in #nmCPRC. Ryan Malone, MD <a href="/1stUrology/">First Urology</a> joins <a href="/zklaassen_md/">Zach Klaassen</a> <a href="/GACancerCenter/">Georgia Cancer Center</a> in this conversation focusing on the evolving role of PSMA PET imaging. #WatchNow &gt; bit.ly/42lRAaT <a href="/BayerUS/">Bayer U.S. 🇺🇸</a>
Jorge Cortes MD (@gcc_cortes) 's Twitter Profile Photo

Early onset colorectal cancer is a growing problem, further enhanced by poverty and rurality. This topic is masterfully analyzed by our start Dr. Mina Tsai from Georgia Cancer Center in this recent manuscript. jamanetwork.com/journals/jaman…

Blood Cancers Today (@blood_cancers) 's Twitter Profile Photo

Olutasidenib continues to produce rapid and durable responses in patients with relapsed or refractory #AML with IDH1 mutation, according to an updated five-year analysis led by Jorge Cortes MD of Georgia Cancer Center. ➡️ buff.ly/3ZsJwWL

Olutasidenib continues to produce rapid and durable responses in patients with relapsed or refractory #AML with IDH1 mutation, according to an updated five-year analysis led by <a href="/GCC_Cortes/">Jorge Cortes MD</a> of <a href="/GACancerCenter/">Georgia Cancer Center</a>.

➡️ buff.ly/3ZsJwWL
UroToday.com (@urotoday) 's Twitter Profile Photo

Managing nonmetastatic castration-resistant #ProstateCancer. Zachary Reardon, MD joins Zach Klaassen Georgia Cancer Center to discuss the nuances of managing #nmCRPC in clinical practice. #WatchNow > bit.ly/43Q6KGr

Managing nonmetastatic castration-resistant #ProstateCancer. Zachary Reardon, MD joins <a href="/zklaassen_md/">Zach Klaassen</a> <a href="/GACancerCenter/">Georgia Cancer Center</a> to discuss the nuances of managing #nmCRPC in clinical practice. #WatchNow &gt; bit.ly/43Q6KGr